By June 2026, 63 countries had eliminated at least one neglected tropical disease, compared with 42 at the end of 2020, according to a World Health Organization assessment published on 4 November 2026. It is a substantial increase in countries reaching recognized disease-specific elimination goals, although it does not mean those diseases have disappeared everywhere.
The report also documents a fall in the number of people requiring treatment or other interventions for neglected tropical diseases. WHO estimates that 1.41 billion people still needed interventions in 2024, down 19% from 2020 and 36% from 2010. Those numbers describe the estimated need for services, not a count of people who received treatment.
How the progress was assessed
The midterm review examines the WHO road map for 21 neglected tropical diseases and disease groups. It draws on 71 indicators reported by countries and a structured assessment informed by more than 350 experts, health officials, researchers and partners. The principal global need estimate uses 2024 data, while the country-elimination count is updated through June 2026. The dates should not be treated as one simultaneous measurement.
The WHO announcement also reports that human Guinea worm cases fell to 10 in 2025 and sleeping sickness cases have dropped by 98% since 1999. The findings reflect years of surveillance, prevention and care by countries and their partners.
Progress is uneven and could be lost
A wider improvement is not the same as every disease moving in the right direction. WHO reports a record 15.1 million dengue cases in 2024, rising deaths from vector-borne neglected tropical diseases and delays in the eradication efforts for yaws and Guinea worm disease. Only three disease-specific indicators reached their 2025 milestones.
Funding is another concern: available resources for these programmes remain 30% below pre-pandemic levels, according to WHO. The report relies on country reporting with acknowledged gaps, including incomplete breakdowns by gender. Anadolu Agency's 4 November report also highlights the funding and data pressures behind the progress.
For communities affected by these diseases, the decline in unmet intervention needs and the growth in elimination milestones matter. Keeping those gains will require sustained diagnosis, treatment, monitoring and investment rather than assuming the work is finished.